(US)
Need an official quote in your mailbox?
Our automated system will send you a quote for your specific qty along with Discount, timelines and Stock status.
5a-ANDROSTAN-11-β-OL-3, 17-DIONE
STEROIDS
| CAT No.# | CS-V-00026 |
| Category | Steroids |
| CAS | 599-11-1 |
| Stock Status |
AVAILABLE
Do you want a quotation or have a question about '5a-ANDROSTAN-11-β-OL-3, 17-DIONE' ? We normally respond within 2 hours.Do you want a quotation or have a question about '5a-ANDROSTAN-11-β-OL-3, 17-DIONE' ? We normally respond within 2 hours.(Available within 3-5 days) Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing. |
| Molecular Weight | 304.4238 |
| Molecular Formula | C19H28O3 |
| Purity: | >98% |
| Synonyms: | (5S,8S,9S,10S,11S,13S,14S)-11-hydroxy-10,13-dimethyldodecahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,4H)-dione |
| Shipping: | Free Shipping for worldwide on order above 2000 USD |
Product rating: 9 5a-ANDROSTAN-11-β-OL-3, 17-DIONE based on 20 ratings
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Palbociclib N-Glucuronide
15. Carpropamid
16. Olmesartan N1-Trityl Impurity
17. 1-Octadecanethiol
18. H-Ser(Bzl)-OBzl . p-tosylate (E-3755.0005)
19. 2-((benzyloxy)(4-ethoxyphenyl)methyl)-4-bromo-1-chlorobenzene
20. α-Pinene oxide
This page contains information about 5a-ANDROSTAN-11-β-OL-3, 17-DIONE Cas 599-11-1 and its Steroids.
5a-ANDROSTAN-11-β-OL-3, 17-DIONE 5a-ANDROSTAN-11-β-OL-3, 17-DIONE Worldwide Suppliers of 5a-ANDROSTAN-11-β-OL-3, 17-DIONE https://www.clearsynth.com/en/CSV00026.html Steroids Clearsynth 599-11-1
"Products currently covered by valid US Patents
are offered for R&D use in accordance with 35 USC 271(e)+A13(1).
Any patent infringement and resulting liability is solely at
buyer risk."